An Observational Study on the Identification of Prescription Patterns of STAFEN Cap

H

Hanlim Pharm

Status

Enrolling

Conditions

Mixed Dyslipidemia

Study type

Observational

Funder types

Industry

Identifiers

NCT06204380
HL-STAF-401

Details and patient eligibility

About

An observational study on the identification of prescription patterns of STAFEN Cap., changes in blood lipid concentration, and statin-related muscle symptoms in Korean patients with mixed dyslipidemia

Full description

This study aims to observe the effectiveness of STAFEN capsule such as changes in blood lipid concentration and safety including statin-related muscle symptoms, and prescription patterns under daily clinical treatment in patients who have been prescribed STAFEN capsules for the treatment of complex dyslipidemia.

Enrollment

4,000 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adults over 19 years of age
  2. A patient diagnosed with mixed dyslipidemia
  3. A patient who was first prescribed a STAFEN cap. for the purpose of treating mixed dyslipidemia according to the clinician's judgment
  4. A patient who voluntarily agreed in writing to this study

Exclusion criteria

  1. Pregnant women, lactating women, or those planning to conceive
  2. A person who is prohibited from administering the STAFEN cap. under the permit
  3. If the person in charge of other clinical studies and the person in charge deems it inappropriate to be the subject of this clinical study

Trial contacts and locations

1

Loading...

Central trial contact

Heebaek Park

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems